整合因子复合物在癌症中的研究
Study on Integrating Factor Complexes in Cancer
DOI: 10.12677/acm.2024.1461746, PDF,   
作者: 牛宗格：山东大学齐鲁医院重症医学科，山东 济南
关键词: 整合因子复合物；癌症；研究进展；Integrating Factor Complex； Cancer； Research Progress
摘要: 在近年来的研究中，整合因子复合物(Integrator complex, INT)在肿瘤生物学领域的重要性逐渐被揭示。这些蛋白在正常细胞中主要负责mRNA的转运与加工。然而，在肿瘤细胞中，由于遗传突变或表达失调，INT的功能常常发生改变，这种变化可能深刻影响肿瘤的形成、发展以及微环境的调控。本综述文章综合分析了最新的研究进展，着重探讨了INT如何通过调节mRNA的加工和转运来影响肿瘤细胞的增殖、侵袭性和抗药性。研究表明，INT在不同类型的肿瘤中展现出不同的表达模式和调控机制。此外，本文还讨论了针对INT功能异常的治疗策略，包括新开发的小分子抑制剂和基因疗法。通过全面回顾相关文献，本文旨在为未来研究提供理论基础和实验依据，尤其是在发展精准医疗和个性化治疗策略方面。
Abstract: In recent years, the importance of integrator complex (INT) in tumor biology has been gradually revealed. These proteins are mainly responsible for mRNA transport and processing in normal cells. However, in tumor cells, the function of INT is often altered due to genetic mutations or dysregulated expression, and such changes may profoundly affect tumor formation, progression, and microenvironment regulation. This review article synthesizes and analyzes recent research advances, focusing on how INT affects tumor cell proliferation, invasiveness, and drug resistance by regulating mRNA processing and trafficking. It is shown that INT exhibits different expression patterns and regulatory mechanisms in different types of tumors. In addition, this paper discusses therapeutic strategies for targeting abnormal INT function, including newly developed small molecule inhibitors and gene therapy. By comprehensively reviewing the relevant literature, this paper aims to provide a theoretical foundation and experimental basis for future research, especially in the development of precision medicine and personalized treatment strategies.
文章引用：牛宗格. 整合因子复合物在癌症中的研究[J]. 临床医学进展, 2024, 14(6): 71-77. https://doi.org/10.12677/acm.2024.1461746

参考文献

[1] Rubtsova, M.P., Vasilkova, D.P., Moshareva, M.A., et al. (2019) Integrator Is a Key Component of Human Telomerase RNA Biogenesis. Scientific Reports, 9, Article No. 1701. [Google Scholar] [CrossRef] [PubMed]
[2] Lai, F., Gardini, A., Zhang, A., et al. (2015) Integrator Mediates the Biogenesis of Enhancer RNAs. Nature, 525, 399-403. [Google Scholar] [CrossRef] [PubMed]
[3] Vervoort, S.J., Welsh, S.A., Devlin, J.R., et al. (2021) The PP2A-Integrator-CDK9 Axis Fine-Tunes Transcription and Can Be Targeted Therapeutically in Cancer. Cell, 184, 3143-3162. [Google Scholar] [CrossRef] [PubMed]
[4] Pfleiderer, M.M. and Galej, W.P. (2021) Structure of the Catalytic Core of the Integrator Complex. Molecular Cell, 81, 1246-1259. [Google Scholar] [CrossRef] [PubMed]
[5] Gardini, A., Baillat, D., Cesaroni, M., et al. (2014) Integrator Regulates Transcriptional Initiation and Pause Release Following Activation. Molecular Cell, 56, 128-139. [Google Scholar] [CrossRef] [PubMed]
[6] Skaar, J.R., Ferris, A.L., Wu, X., et al. (2015) The Integrator Complex Controls the Termination of Transcription at Diverse Classes of Gene Targets. Cell Research, 25, 288-305. [Google Scholar] [CrossRef] [PubMed]
[7] Baillat, D., Hakimi, M.A., Naar, A.M., et al. (2005) Integrator, a Multiprotein Mediator of Small Nuclear RNA Processing, Associates with the C-Terminal Repeat of RNA Polymerase II. Cell, 123, 265-276. [Google Scholar] [CrossRef] [PubMed]
[8] Chen, J., Ezzeddine, N., Waltenspiel, B., et al. (2012) An RNAi Screen Identifies Additional Members of the Drosophila Integrator Complex and a Requirement for Cyclin C/Cdk8 in snRNA 3’-End Formation. RNA, 18, 2148-2156. [Google Scholar] [CrossRef] [PubMed]
[9] Hata, T. and Nakayama, M. (2007) Targeted Disruption of the Murine Large Nuclear KIAA1440/Ints1 Protein Causes Growth Arrest in Early Blastocyst Stage Embryos and Eventual Apoptotic Cell Death. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1773, 1039-1051.
[10] Wu, Y., Albrecht, T.R., Baillat, D., et al. (2017) Molecular Basis for the Interaction between Integrator Subunits IntS9 and IntS11 and Its Functional Importance. Proceedings of the National Academy of Sciences of the United States of America, 114, 4394-4399. [Google Scholar] [CrossRef] [PubMed]
[11] Albrecht, T.R., Shevtsov, S.P., Wu, Y., et al. (2018) Integrator Subunit 4 Is a ‘Symplekin-Like’ Scaffold that Associates with INTS9/11 to Form the Integrator Cleavage Module. Nucleic Acids Research, 46, 4241-4255. [Google Scholar] [CrossRef] [PubMed]
[12] Kirstein, N., Gomes Dos Santos, H., Blumenthal, E., et al. (2021) The Integrator Complex at the Crossroad of Coding and Noncoding RNA. Current Opinion in Cell Biology, 70, 37-43. [Google Scholar] [CrossRef] [PubMed]
[13] Wei, X., Li, X., Hu, S., et al. (2023) Regulation of Ferroptosis in Lung Adenocarcinoma. International Journal of Molecular Sciences, 24, Article 144614. [Google Scholar] [CrossRef] [PubMed]
[14] Davidson, L., Francis, L., Eaton, J.D., et al. (2020) Integrator-Dependent and Allosteric/Intrinsic Mechanisms Ensure Efficient Termination of snRNA Transcription. Cell Reports, 33, Article 108319. [Google Scholar] [CrossRef] [PubMed]
[15] Elrod, N.D., Henriques, T., Huang, K.-L., et al. (2019) The Integrator Complex Attenuates Promoter-Proximal Transcription at Protein-Coding Genes. Molecular Cell, 76, 738-752. [Google Scholar] [CrossRef] [PubMed]
[16] Lykke-andersen, S., Zumer, K., Molska, E.S., Schmid, M., et al. (2021) Integrator Is a Genome-Wide Attenuator of Non-Productive Transcription. Molecular Cell, 81, 514-529. [Google Scholar] [CrossRef] [PubMed]
[17] Tatomer, D.C., Elrod, N.D., Liang, D., et al. (2019) The Integrator Complex Cleaves Nascent MRNAs to Attenuate Transcription. Genes & Development, 33, 1525-1538. [Google Scholar] [CrossRef] [PubMed]
[18] Cheng, L., Zhang, Q., Yang, S., et al. (2013) A 4-Gene Panel as a Marker at Chromosome 8q in Asian Gastric Cancer Patients. Genomics, 102, 323-330. [Google Scholar] [CrossRef] [PubMed]
[19] Yoshimi, A., Lin, K.-T., Wiseman, D.H., et al. (2019) Coordinated Alterations in RNA Splicing and Epigenetic Regulation Drive Leukaemogenesis. Nature, 574, 273-277. [Google Scholar] [CrossRef] [PubMed]
[20] Krall, M., Htun, S., Schnur, R.E., et al. (2019) Biallelic Sequence Variants in INTS1 in Patients with Developmental Delays, Cataracts, and Craniofacial Anomalies. European Journal of Human Genetics, 27, 582-593. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, Z., Zhang, C., Guo, J., et al. (2024) CRISPR-Cas9 Screening Identifies INTS3 as an Anti-Apoptotic RNA-Binding Protein and Therapeutic Target for Colorectal Cancer. iScience, 27, Article 109676. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, Y., Koe, C.T., Tan, Y.S., et al. (2019) The Integrator Complex Prevents Dedifferentiation of Intermediate Neural Progenitors Back into Neural Stem Cells. Cell Reports, 27, 987-996. [Google Scholar] [CrossRef] [PubMed]
[23] Vazanova, A., Jurecekova, J., Balharek, T., et al. (2018) Differential mRNA Expression of the Main Apoptotic Proteins in Normal and Malignant Cells and Its Relation to in vitro Resistance. Cancer Cell International, 18, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[24] Zhuang, H., Yu, B., Tao, D., et al. (2023) The Role of m6A Methylation in Therapy Resistance in Cancer. Molecular Cancer, 22, Article No. 91. [Google Scholar] [CrossRef] [PubMed]
[25] Oegema, R., Baillat, D., Schot, R., et al. (2017) Human Mutations in Integrator Complex Subunits Link Transcriptome Integrity to Brain Development. PLOS Genetics, 13, e1006923. [Google Scholar] [CrossRef] [PubMed]
[26] Dominski, Z., Yang, X.-C., Purdy, M., et al. (2005) A CPSF-73 Homologue Is Required for Cell Cycle Progression but Not Cell Growth and Interacts with a Protein Having Features of CPSF-100. Molecular and Cellular Biology, 25, 1489-1500. [Google Scholar] [CrossRef] 
[27] Tong, H., Liu, X., Li, T., et al. (2019) INTS8 Accelerates the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma by Upregulating the TGF-Beta Signaling Pathway. Cancer Management and Research, 11, 1869-1879. [Google Scholar] [CrossRef] 
[28] Zhou, Q., Ji, L., Shi, X., et al. (2021) INTS8 Is a Therapeutic Target for Intrahepatic Cholangiocarcinoma via the Integration of Bioinformatics Analysis and Experimental Validation. Scientific Reports, 11, Article No. 23649. [Google Scholar] [CrossRef] [PubMed]
[29] Hecht, S.S. (2008) Progress and Challenges in Selected Areas of Tobacco Carcinogenesis. Chemical Research in Toxicology, 21, 160-171. [Google Scholar] [CrossRef] [PubMed]
[30] Emran, T.B., Shahriar, A., Mahmud, A.R., et al. (2022) Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Frontiers in Oncology, 12, Article 891652. [Google Scholar] [CrossRef] [PubMed]
[31] Hu, S., Peng, L., Song, A., et al. (2023) INTAC Endonuclease and Phosphatase Modules Differentially Regulate Transcription by RNA Polymerase II. Molecular Cell, 83, 1588-1604. [Google Scholar] [CrossRef] [PubMed]
[32] Tilley, F.C., Arrondel, C., Chhuon, C., et al. (2021) Disruption of Pathways Regulated by Integrator Complex in Galloway-Mowat Syndrome due to WDR73 Mutations. Scientific Reports, 11, Article No. 5388. [Google Scholar] [CrossRef] [PubMed]
[33] Tepe, B., Macke, E.L., Niceta, M., et al. (2023) Bi-Allelic Variants in INTS11 Are Associated with a Complex Neurological Disorder. American Journal of Human Genetics, 110, 774-789. [Google Scholar] [CrossRef] [PubMed]
[34] Shersher, E., Lahiry, M., Alvarez-Trotta, A., et al. (2021) NACK and INTEGRATOR Act Coordinately to Activate Notch-Mediated Transcription in Tumorigenesis. Cell Communication and Signaling, 19, Article No. 96. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, S.-W., Gao, C., Zheng, Y.-M., et al. (2022) Current Applications and Future Perspective of CRISPR/Cas9 Gene Editing in Cancer. Molecular Cancer, 21, Article No. 57. [Google Scholar] [CrossRef] [PubMed]

为你推荐